Scholarlink

<p>Lung Squamous Cell Carcinoma (LUSC), a common subtype of non-small cell lung cancer, primarily occurs in elderly individuals and is closely linked to senescence-related biological processes. Meanwhile, senescence reshapes the tumor microenvironment by promoting immune suppression and angiogenesis, and its underlying mechanisms remain unclear. Here, we identified three senescence-related molecular subtypes of LUSC, each with distinct clinical outcomes, genomic alterations, and immune features. Among them, Cluster 1 was associated with poor prognosis, increased genomic instability, and an immunosuppressive TME enriched with senescence signatures. To uncover the underlying mechanisms, we integrated bulk and single-cell transcriptomic data and found extensive senescence reprogramming across epithelial, myeloid, and T/NK cell compartments. Notably, senescent immune subsets-such as S100A9 + macrophages and TNFRSF4 + Tregs-were markedly enriched in older patients. Furthermore, cell communication analysis revealed enhanced intercellular signaling in senescent cells. Based on these findings, we constructed a robust machine learning-based prognostic model incorporating senescent gene expression and cell-type abundance to predict survival and immunotherapy response. Finally, functional validation demonstrated that UGT1A7 acts as a pro-proliferative driver that is significantly downregulated during the induction of cellular senescence. Experimental depletion of UGT1A7 phenocopies this senescence-associated decline, thereby triggering growth arrest and inhibiting tumor progression, suggesting its potential as a therapeutic target. Our study reveals how senescence-related alterations in cellular composition and transcriptional dysregulation reshape the tumor microenvironment, providing novel biomarkers and a theoretical basis for therapy.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Integrative profiling of senescence-associated cells and genes identifies UGT1A7 as a prognostic and therapeutic target in Lung squamous cell carcinoma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月8日

查看全文
  • Shengqiang Mao,
  • Tong Deng,
  • Zhiqiang Liu,
  • Renxin Ding,
  • Lei Li,
  • Yidan Lin

摘要

Lung Squamous Cell Carcinoma (LUSC), a common subtype of non-small cell lung cancer, primarily occurs in elderly individuals and is closely linked to senescence-related biological processes. Meanwhile, senescence reshapes the tumor microenvironment by promoting immune suppression and angiogenesis, and its underlying mechanisms remain unclear. Here, we identified three senescence-related molecular subtypes of LUSC, each with distinct clinical outcomes, genomic alterations, and immune features. Among them, Cluster 1 was associated with poor prognosis, increased genomic instability, and an immunosuppressive TME enriched with senescence signatures. To uncover the underlying mechanisms, we integrated bulk and single-cell transcriptomic data and found extensive senescence reprogramming across epithelial, myeloid, and T/NK cell compartments. Notably, senescent immune subsets-such as S100A9 + macrophages and TNFRSF4 + Tregs-were markedly enriched in older patients. Furthermore, cell communication analysis revealed enhanced intercellular signaling in senescent cells. Based on these findings, we constructed a robust machine learning-based prognostic model incorporating senescent gene expression and cell-type abundance to predict survival and immunotherapy response. Finally, functional validation demonstrated that UGT1A7 acts as a pro-proliferative driver that is significantly downregulated during the induction of cellular senescence. Experimental depletion of UGT1A7 phenocopies this senescence-associated decline, thereby triggering growth arrest and inhibiting tumor progression, suggesting its potential as a therapeutic target. Our study reveals how senescence-related alterations in cellular composition and transcriptional dysregulation reshape the tumor microenvironment, providing novel biomarkers and a theoretical basis for therapy.